Enterococci are responsible for serious diseases such as urinary tract infections (cystitis, urethritis, pyelonephritis and prostatis), bacteremia, intra-abdominal, pelvic and soft tissue infections. Infection on burn surfaces were also commonly caused by Enterococcus. The ability of enterococci to cause such diseases is due to acquisition of certain virulence factors such as hemolysin, gelatinase, Biofilm formation and enterococcus surface protein (esp). This study has been conducted to investigate the occurrence of virulence factors between Enterococcus isolated from nosocomial infections and from stool samples (commensal isolates).Both clinical and stool specimens were collected and isolates were identified by microscopic, culture and standard biochemical tests. Virulence factors were examined by phenotypic tests and esp gene were detected by PCR method.There is no significant difference in the virulence factors like hemolysin and gelatinase production between clinical and commensal isolates. Biofilm production and presence of esp gene is very high among clinical isolates. Study of virulence factors associated with invasiveness and disease producing capacity of nosocomial pathogen like multidrug resistant Enterococcus will be very useful in treating them.
Enterococcus, the gram positive cocci are part of normal flora of human intestine, biliary tract and to lesser extent vagina and male urethra. However the incidence of Enterococcal infections, especially nosocomial infection, has dramatically increased over last 25 years 1, 2 . Enterococci have been implicated in clinical conditions like urinary tract infections (cystitis, urethritis, pyelonephritis and prostatis), bacteremia, intra-abdominal, pelvic and soft tissue infections. Infection on burn surfaces were also commonly caused by Enterococcus.
Enterococcus faecalis is the most common species found in clinical specimens when compared with Enterococcus faecium. Enterococcus faecium is more drug resistant than Enterococcus faecalis 3 . Most strains of Enterococcus are resistant to penicillin, aminoglycosides and sulphonamides. They show intrinsic resistance to cephalosporins and Cotrimoxazole.
Enterococcus exhibit a number of virulence factors. These virulence factors may contribute to the ability of Enterococcus to cause diseases 4 . Adherence of Enterococcus to host cell is the important step in the pathogenesis of infection, which is achieved by adhesion factor called Enterococcal surface protein (esp) 5 . Enterococcus also secrete hemolysin (cytolysin protein), a bacterial toxin that produce haemolytic activity against erythrocytes of human, horse and rabbit. Another secreted molecule is gelatinase which hydrolyse collagen, casein, haemoglobin and other peptides 6 . Esp is found to be one of the important virulence factor to enhance the persistence of Enterococcus in urinary bladder during experimental urinary tract infections 7 . Gelatinase plays an important role in the pathogenesis of endocarditis in an animal model 6 . Hemolysin producing strains were found to be associated in severe infections. All these factors have been associated with the virulence of Enterococcus in animal models. It is not very clear, the presence of virulence factors in Enterococcus from clinical and commensal isolates contribute to the virulence in humans.
The present study aims to compare the production of these virulence factors between Enterococcus isolated from nosocomial infections and from stool samples, i.e comparison between clinical and commensal isolates.
MATERIALS AND METHODS
One hundred and twenty clinical isolates of Enterococcus species were isolated over a period of six months (January 2015-June 2015) from a tertiary care centre, Chennai. 100 commensal isolates of Enterococcus collected from stool samples (faecal flora) were included in this study.
Enterococcus species were isolated from clinical samples such as exudates (postoperative wound infection, diabetic foot ulcers, infected fractures, and burns), septicaemia, endotracheal infection and urinary tract infection. Enterococcus is confirmed by microscopic examination, standard biochemical tests and by culture methods 8 .
Virulence factors detection Gelatinase assay
Gelatinase production was detected by inoculation of the organism into tubes containing 12% gelatine in 0.8% nutrient broth. These tubes were incubated for 24 hours at 37 0 c and then placed in the refrigerator for approximately 30 minutes. The liquefaction of gelatine was considered as a positive test 9 .
Hemolysin production
To determine hemolysin (cytolysin protein) production, isolates were inoculated on brain-heart infusion gar supplemented with 5% sheep blood. These agar plates were incubated at 37 0 c for 24 hours. A clear zone of beta hemolysis around the bacterial colonies indicates the hemolysin activity 10 .
Biofilm formation
Quantitative adherence assay was the method used to detect the Biofilm formation 11 . Enterococcus species were inoculated into trypticase soy broth with 0.5% glucose and incubated at 37 0 c for overnight. 200µl of 1: 40 dilution of overnight culture in trypticase -soy broth with 0.5% glucose was inoculated into the wells of micro titre plate and incubated for 48 hours at 37 o c. Then the wells were gently washed three times with phosphate buffered saline (PBS). The adherent bacterial film was fixed by air drying at 60 0 c for one hour and then stained with 0.1% safranin and allowed to stand for 20 minutes at room temperature. The absorbance of the Biofilm was measured at 49nm in an ELISA (Enzyme linked immunosorbent assay) reader. Biofilm measurements were repeated for three times in triplicate for each strain. Mean optical density (OD) value of the positive control was considered as standard. Ability of the strain to produce Biofilm were scored as follows, if the OD value is more than 0.2, they are strong Biofilm producer. OD value which is below 0.120 is Biofilm non producer and if OD value is between 0.120 and 0.2 then it is considered as weak Biofilm producer. Enterococcal surface protein (esp) gene detection DNA was extracted from Enterococcus species using Purefast bacterial DNA minispin purification kit accordance with manufacturer's protocol. PCR reaction was performed for the amplification of the 300bp fragment of esp gene using following primer.
esp gene
Forward primer 5'-AAGTGTGGGTGTTG CATCAG-3' Reverse primer 5'-TCCCAGTTTGCAGTTGAAGC-3' PCR amplification reaction mixture (25µl) contained 10µl probe PCR master mix, 5µl primer forward, 5µl of primer reverse and 5µl of purified genomic DNA. PCR conditions were as follows: Taq enzyme activation at 94  0 c for 3 minutes, 35  cycles 
RESULTS
The study was undertaken in a tertiary care centre, Chennai for a period of six months(January 2015-June 2015) .One hundred and twenty isolates of Enterococcus species isolated from various clinical infections and 100 commensal isolates of Enterococcus collected from stool samples (faecal flora) were included in this study.
Among the 120 clinical isolates of Enterococcus species , n=78(65%) were from post operative wound infection, followed by diabetic foot ulcer, urinary tract infection, endotracheal infection, infected fracture, burns and septicaemia. Enterococcus strains isolated from various clinical infection shown in Table 1 Production of virulence factors between clinical and commensal Enterococcus species are shown in Table 2 : Clinical sample wise production of virulence factors like Gelatinase, hemolysin, Biofilm formation and esp gene expression are shown in Table 3 . Esp gene expression is shown in Fig 1. Almost all strains causing urinary tract infection, endotracheal infection, infected fracture and septicaemia produced more virulent factors.
Among the clinical Enterococcus isolates, 16 strains produced all 3 virulence factors, Gelatinase and hemolysin were produced by 9 strains, Gelatinase and Biofilm were produced by 15 strains and Hemolysin and Biofilm production is seen in 3 strains. Only Gelatinase is produced by 17 strains, hemolysin produced by 3 strains and Biofilm production is seen in 17 strains. (Table  4) Among commensal Enterococcus isolates, 5 strains produced all 3 virulence factors, Gelatinase and hemolysin were produced by 6 strains, Gelatinase and Biofilm were produced by 10 strains and Hemolysin and Biofilm production is seen in 3 strains. Only Gelatinase is produced by 18 strains, hemolysin produced by 3 strains and Biofilm production is seen in 2 strains.
DISCUSSION
Enterococcus is an important cause of nosocomial infections 12 . We studied the prevalence of virulence factors like gelatinase, hemolysin, Biofilm formation and presence of esp gene between clinical isolates and commensal isolates of Enterococcus. Both clinical isolates and commensal isolates showed the presence of the virulence factors singly or in combination. Although these factors are very much important in the pathogenesis of disease, their contribution in the clinical isolates and commensal isolates were yet to be researched. In our study, with respect to the virulence factors hemolysin and gelatinase production, there is no significant difference between clinical and commensal isolates which is similar to other studies 6, 20 . But nowadays many studies on the virulence factors of Enterococcus mainly focussed on biofilm formation and the presence of a gene coding for enteococcal surface protein (esp), besides the well known aggregative substance, gelatinase and hemolysin 15, 20 . Biofilm production is an important factor which makes the organism to adhere onto surfaces, which in turn help it to invade and cause disease 5 . In this study, Biofilm production is very high among clinical isolates from urinary tract infection, endotracheal infection and septicaemia, which correlate with other studies 15 . Thus biofilm production in nosocomial strains of organism is an important pathogenic factor in causing infection in the hospital environment 15, 21 . In some studies, the ability of the Enterococcus to produce Biofilm was linked to the presence of esp 13, 14 , while in other studies, there is no much association between biofilm formation and presence of esp gene 16, 17, 18 . In our study more than 70% strains producing biofilm showed the presence of esp gene in clinical isolates.
In our study the clinical isolates also predominantly produce the combination of gelatinase and biofilm formation, which correlate with a study of Hancock & Perga 19 . In Hancock's study, he had explained the association of gelatinase and esp with biofilm formation in Enterococcus species. He identified a two component system, the fsr locus that affected the formation of biofilm through the regulation of gelatinase, which depend on cell density. The gelatinase and esp gene with biofilm formation may act in syngery to establish the infection.
Hence Enterococcus is an important nosocomial pathogen with increasing prevalence of MDR Enterococcus (Multidrug resistant) 21 .
CONCLUSION
Our data says there is no significant difference between clinical and commensal isolates in the production of virulence factors like hemolysin and gelatinase. Biofilm production is very high among clinical isolates from urinary tract infection, endotracheal infection and septicaemia. Combination of gelatinase and biofilm formation is high among clinical isolates. Thus the identification of virulence factors associated with invasiveness and disease severity has become an important subject for research. Development of some mechanisms to inhibit the virulence factors like preventing Biofilm production will be very useful in treating the nosocomial pathogen like multidrug resistant Enterococcus.
